iA Global Asset Management Inc. Has $1.77 Million Stock Holdings in The Clorox Company $CLX

iA Global Asset Management Inc. lifted its stake in The Clorox Company (NYSE:CLX) by 51.3% during the second quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 14,768 shares of the company’s stock after acquiring an additional 5,006 shares during the quarter. iA Global Asset Management Inc.’s holdings in Clorox were worth $1,773,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also modified their holdings of the stock. Vanguard Group Inc. grew its stake in Clorox by 0.4% in the first quarter. Vanguard Group Inc. now owns 15,573,076 shares of the company’s stock valued at $2,293,135,000 after purchasing an additional 65,924 shares in the last quarter. Northern Trust Corp grew its stake in Clorox by 2.3% in the first quarter. Northern Trust Corp now owns 1,528,920 shares of the company’s stock valued at $225,133,000 after purchasing an additional 34,655 shares in the last quarter. Invesco Ltd. grew its stake in Clorox by 7.4% in the first quarter. Invesco Ltd. now owns 1,361,710 shares of the company’s stock valued at $200,512,000 after purchasing an additional 94,371 shares in the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC grew its stake in Clorox by 3.7% in the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 1,157,257 shares of the company’s stock valued at $170,406,000 after purchasing an additional 41,485 shares in the last quarter. Finally, Hsbc Holdings PLC grew its stake in Clorox by 118.8% in the first quarter. Hsbc Holdings PLC now owns 1,085,661 shares of the company’s stock valued at $159,699,000 after purchasing an additional 589,544 shares in the last quarter. Institutional investors and hedge funds own 78.53% of the company’s stock.

Clorox Price Performance

Shares of NYSE CLX opened at $109.16 on Tuesday. The stock has a market capitalization of $13.29 billion, a PE ratio of 16.74, a P/E/G ratio of 0.92 and a beta of 0.52. The company has a debt-to-equity ratio of 5.15, a current ratio of 0.84 and a quick ratio of 0.57. The business has a fifty day moving average price of $120.28 and a two-hundred day moving average price of $125.61. The Clorox Company has a fifty-two week low of $108.93 and a fifty-two week high of $171.37.

Clorox (NYSE:CLX) last announced its quarterly earnings data on Monday, November 3rd. The company reported $0.85 earnings per share for the quarter, beating the consensus estimate of $0.78 by $0.07. Clorox had a return on equity of 377.86% and a net margin of 11.40%.Clorox’s revenue was down 18.9% compared to the same quarter last year. During the same period in the previous year, the firm posted $1.86 earnings per share. Clorox has set its FY 2026 guidance at 5.950-6.300 EPS. As a group, equities analysts predict that The Clorox Company will post 7.15 earnings per share for the current fiscal year.

Clorox Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Thursday, November 6th. Stockholders of record on Wednesday, October 22nd will be issued a dividend of $1.24 per share. The ex-dividend date of this dividend is Wednesday, October 22nd. This represents a $4.96 dividend on an annualized basis and a dividend yield of 4.5%. Clorox’s payout ratio is 76.07%.

Insider Activity at Clorox

In other news, COO Eric H. Reynolds sold 15,041 shares of the business’s stock in a transaction on Thursday, September 4th. The stock was sold at an average price of $123.78, for a total transaction of $1,861,774.98. Following the completion of the transaction, the chief operating officer owned 54,221 shares of the company’s stock, valued at approximately $6,711,475.38. The trade was a 21.72% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Company insiders own 0.63% of the company’s stock.

Analysts Set New Price Targets

CLX has been the subject of several research analyst reports. The Goldman Sachs Group reduced their target price on Clorox from $115.00 to $110.00 and set a “sell” rating for the company in a research note on Wednesday, October 1st. Wells Fargo & Company reduced their target price on Clorox from $130.00 to $125.00 and set an “equal weight” rating for the company in a research note on Thursday, September 25th. TD Cowen reduced their target price on Clorox from $120.00 to $117.00 and set a “hold” rating for the company in a research note on Wednesday, October 1st. BNP Paribas Exane reduced their target price on Clorox from $118.00 to $110.00 and set an “underperform” rating for the company in a research note on Friday, October 17th. Finally, UBS Group reduced their target price on Clorox from $134.00 to $128.00 and set a “neutral” rating for the company in a research note on Wednesday, October 8th. One investment analyst has rated the stock with a Buy rating, eleven have issued a Hold rating and five have issued a Sell rating to the company. According to MarketBeat.com, the stock has a consensus rating of “Reduce” and a consensus price target of $130.20.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.